Advertisement

Topics

ACE Inhibitors, Beta-Blockers Could Mediate Trastuzumab Cardiac Toxicity

07:24 EST 1 Dec 2016 | Cancer Networks

In patients with HER2-positive breast cancer undergoing trastuzumab therapy, the use of an ACE inhibitor or beta-blocker could protect against cardiac toxicity.

Original Article: ACE Inhibitors, Beta-Blockers Could Mediate Trastuzumab Cardiac Toxicity

NEXT ARTICLE

More From BioPortfolio on "ACE Inhibitors, Beta-Blockers Could Mediate Trastuzumab Cardiac Toxicity"

Quick Search
Advertisement
 

Relevant Topic

Breast Cancer
Track and monitor developments in breast cancer research and commercial development.  Follow the tabs above to read the latest global news, research, clinical trials on breast cancer and follow companies active in the development of breast cancer tr...